Drug Type Small molecule drug |
Synonyms AG 86893 |
Target |
Mechanism RTK inhibitors(Receptor protein-tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperemia | Phase 2 | AU | 11 Oct 2018 | |
Pterygium | Phase 2 | AU | 11 Oct 2018 |
Phase 2 | 64 | Vehicle Eye Drops (Vehicle Eye Drops) | ytqrvtbkyl(fgjjqlckgu) = xkfbwnnaif yflyphlenv (ooshirqgtm, snoulpqnqv - pxcljqrwme) View more | - | 06 Nov 2020 | ||
(0.1% AG-86893 Eye Drops) | ytqrvtbkyl(fgjjqlckgu) = jszruowwde yflyphlenv (ooshirqgtm, ftytiztzvl - mbfbmmghmu) View more |